REGN Competitors & Alternatives
Compare Regeneron Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
REGN
Main Stock$620.32
Tradestie Score
59
Market Cap
$63.59B
P/E Ratio
14.9
Revenue Growth
0.2%
Analyst Upside
+34.3%
Top Competitors
222 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals Inc
|
$468.66
|
$103.64B | 26.8 | 69 | Compare |
|
ALNY
Alnylam Pharmaceuticals, Inc.
|
$287.22
|
$60.38B | 69.9 | 55 | Compare |
|
ARGX
argenx SE American Depositary Shares
|
$925.49
|
$46.96B | 40.2 | 64 | Compare |
|
ONC
BeOne Medicines Ltd. American Depositary Shares
|
$274.19
|
$36.81B | 61.0 | 53 | Compare |
|
INSM
Insmed, Inc.
|
$99.11
|
$31.13B | - | 56 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$91.47
|
$24.57B | - | 56 | Compare |
|
BIIB
Biogen Inc. Common Stock
|
$200.70
|
$22.61B | 21.1 | 60 | Compare |
|
GMAB
Genmab A/S ADS
|
$26.05
|
$19.56B | 19.3 | 55 | Compare |
|
INCY
Incyte Genomics Inc
|
$104.26
|
$16.93B | 13.9 | 59 | Compare |
|
ILMN
Illumina Inc
|
$164.54
|
$15.72B | 29.4 | 55 | Compare |
More REGN Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2834)
222 stocks in this industry